Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing.

doi:10.1007/s12020-023-03368-w

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing.

Endocrine - 1 Aug 2023

Elisei Rossella, Romei Cristina

Abstract excerpt

PURPOSE: Thyroid carcinoma (TC) is a rare neoplasia of the endocrine system and account for about 2-3% of all human tumors. According to their cell origin and histological features, different histotypes of thyroid carcinoma are described. Genetic alterations involved in the pathogenesis of thyroid cancer have been described and it has been shown that alterations of the RET gene are common events in all TC...

Topics

Humans
Carcinoma, Medullary
Clinical Relevance
Multiple Endocrine Neoplasia Type 2a
Proto-Oncogene Proteins c-ret
Proto-Oncogene Mas
Thyroid Neoplasms
Mutation

Source

Open in PubMed

Identifiers

PMID: 37195581
DOI: 10.1007/s12020-023-03368-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics